2,394 Cardinal Health, Inc. $CAH Shares Purchased by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.5% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 99,240 shares of the company’s stock after purchasing an additional 2,394 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cardinal Health were worth $22,081,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of CAH. BlackRock Inc. purchased a new position in shares of Cardinal Health in the 2nd quarter valued at $6,293,115,000. Wellington Management Group LLP lifted its holdings in shares of Cardinal Health by 247.5% during the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock valued at $3,530,206,000 after acquiring an additional 10,584,119 shares in the last quarter. Bank of America Corp DE acquired a new position in shares of Cardinal Health during the 2nd quarter valued at $689,066,000. Legal & General Group Plc purchased a new stake in Cardinal Health during the 2nd quarter worth $438,870,000. Finally, Pacer Advisors Inc. boosted its position in Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock worth $330,728,000 after purchasing an additional 200,021 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Michelle D. Greene sold 11,650 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the sale, the insider directly owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Deborah Weitzman sold 7,354 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares in the company, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 in the last three months. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Trading Down 0.0%

CAH opened at $257.50 on Thursday. Cardinal Health, Inc. has a twelve month low of $157.79 and a twelve month high of $259.09. The firm has a market cap of $59.63 billion, a price-to-earnings ratio of 35.62, a PEG ratio of 1.55 and a beta of 0.50. The company has a fifty day simple moving average of $235.68 and a 200 day simple moving average of $223.25.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were issued a $0.5158 dividend. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. Cardinal Health’s dividend payout ratio is currently 28.49%.

Analysts Set New Price Targets

CAH has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price target on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Morgan Stanley boosted their price objective on Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Bank of America upped their target price on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. Wells Fargo & Company increased their target price on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Finally, Leerink Partners set a $292.00 target price on Cardinal Health in a report on Tuesday, August 11th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $269.38.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.